Retinal dehydrogenase-2 is inhibited by compounds that induce congenital diaphragmatic hernias in rodents

Jörg Mey1, Randal P Babiuk, Robin Clugston

  • 1Institut für Biologie II, Aachen, Germany.

Insights

Congenital diaphragmatic hernia (CDH) causes are unknown. This study found four teratogens inhibit retinal dehydrogenase-2 (RALDH2), suggesting retinoid signaling disruption in CDH development.

Area of Science:

  • Developmental biology
  • Teratology
  • Biochemistry

Background:

  • Congenital diaphragmatic hernia (CDH) is a severe birth defect with an unknown cause.
  • Understanding CDH etiology is crucial for developing preventative strategies and treatments.

Purpose of the Study:

  • To investigate the underlying molecular mechanisms of CDH using an animal model.
  • To test the hypothesis that teratogens causing CDH share a common mechanism involving retinoid signaling.

Main Methods:

  • Utilized an established rat model of CDH.
  • Characterized four teratogens (nitrofen, 4-biphenyl carboxylic acid, bisdiamine, SB-210661) that induce diaphragmatic defects.
  • Assayed inhibition of retinal dehydrogenase-2 (RALDH2) by measuring retinoic acid production in cytosolic extracts.

Main Results:

  • All four tested teratogens induced posterolateral diaphragmatic defects in embryonic rats.
  • Demonstrated that these teratogens share a common mechanism of inhibiting RALDH2, a key enzyme in retinoic acid synthesis.
  • RALDH2 is expressed in the developing diaphragm, linking its inhibition to CDH pathogenesis.

Conclusions:

  • Perturbation of the retinoid signaling pathway, specifically RALDH2 inhibition, is a shared mechanism among teratogens causing CDH.
  • These findings provide critical insights into the etiology of CDH.
  • The retinoid system should be considered in future research on CDH development.

Related Concept Videos